Cell Therapy Market Report

Europe Cell Therapy Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 10, 2020
  • PAGES：236
  • REPORT CODE：GMM541539
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Cell Therapy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 1.8% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Cell Therapy Market Segmentations:

    By Player:

    • Astellas Pharma

    • Avita Medical

    • Capricor Therapeutics

    • BioTissue Technologies

    • Cell Medica

    • BIOTIME

    • CellBioMed

    • Caladrius

    • Vericel

    • Biogen Idec

    • Athersys

    • Bluebird Bio

    • Antibe Therapeutics

    • Celgene

    • Dendreon

    • Amorcyte

    • BIOCELLULAR THERAPIES

    • Mesoblast

    • Bellicum Pharmaceuticals

    • AlloCure

    • AxoGen

    • Bone Therapeutics

    • BrainStorm Cell Therapeutics

    • Anterogen

    • BioCardia

    • Bio-Tissue

    By Type:

    • Nanotechnology

    • Natural Substances

    By End-User:

    • Scientific Research

    • Hospital

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cell Therapy Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Cell Therapy Market Size and Growth Rate of Nanotechnology from 2014 to 2026

    • 1.3.2 Europe Cell Therapy Market Size and Growth Rate of Natural Substances from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Cell Therapy Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • 1.4.2 Europe Cell Therapy Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.3 Europe Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Cell Therapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cell Therapy by Major Types

      • 3.4.1 Market Size and Growth Rate of Nanotechnology

      • 3.4.2 Market Size and Growth Rate of Natural Substances

    4 Segmentation of Cell Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cell Therapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Scientific Research for Construction

      • 4.4.2 Market Size and Growth Rate of Hospital for Construction

      • 4.4.3 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Cell Therapy Production Analysis by Top Regions

    • 5.2 Europe Cell Therapy Consumption Analysis by Top Regions

    • 5.3 Europe Cell Therapy Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.3 France Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Production, Import, Consumption and Export Analysis

    6 Product Circulation of Cell Therapy Market among Top Countries

    • 6.1 Top 5 Export Countries in Cell Therapy Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Cell Therapy Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Cell Therapy Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Cell Therapy Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Cell Therapy Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Cell Therapy Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Cell Therapy Landscape Analysis

    • 7.1 Germany Cell Therapy Landscape Analysis by Major Types

    • 7.2 Germany Cell Therapy Landscape Analysis by Major End-Users

    8. UK Cell Therapy Landscape Analysis

    • 8.1 UK Cell Therapy Landscape Analysis by Major Types

    • 8.2 UK Cell Therapy Landscape Analysis by Major End-Users

    9. France Cell Therapy Landscape Analysis

    • 9.1 France Cell Therapy Landscape Analysis by Major Types

    • 9.2 France Cell Therapy Landscape Analysis by Major End-Users

    10. Italy Cell Therapy Landscape Analysis

    • 10.1 Italy Cell Therapy Landscape Analysis by Major Types

    • 10.2 Italy Cell Therapy Landscape Analysis by Major End-Users

    11. Spain Cell Therapy Landscape Analysis

    • 11.1 Spain Cell Therapy Landscape Analysis by Major Types

    • 11.2 Spain Cell Therapy Landscape Analysis by Major End-Users

    12. Poland Cell Therapy Landscape Analysis

    • 12.1 Poland Cell Therapy Landscape Analysis by Major Types

    • 12.2 Poland Cell Therapy Landscape Analysis by Major End-Users

    13. Russia Cell Therapy Landscape Analysis

    • 13.1 Russia Cell Therapy Landscape Analysis by Major Types

    • 13.2 Russia Cell Therapy Landscape Analysis by Major End-Users

    14. Switzerland Cell Therapy Landscape Analysis

    • 14.1 Switzerland Cell Therapy Landscape Analysis by Major Types

    • 14.2 Switzerland Cell Therapy Landscape Analysis by Major End-Users

    15. Turkey Cell Therapy Landscape Analysis

    • 15.1 Turkey Cell Therapy Landscape Analysis by Major Types

    • 15.2 Turkey Cell Therapy Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Landscape Analysis by Top Countries

      • 16.3.1 Denmark Cell Therapy Market Volume and Growth Rate

      • 16.3.2 Finland Cell Therapy Market Volume and Growth Rate

      • 16.3.3 Norway Cell Therapy Market Volume and Growth Rate

      • 16.3.4 Sweden Cell Therapy Market Volume and Growth Rate

      • 16.3.6 Iceland Cell Therapy Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Landscape Analysis by Top Countries

      • 17.3.1 Belgium Cell Therapy Market Volume and Growth Rate

      • 17.3.2 Netherlands Cell Therapy Market Volume and Growth Rate

      • 17.3.3 Luxembourg Cell Therapy Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Landscape Analysis by Top Countries

      • 18.3.1 Estonia Cell Therapy Market Volume and Growth Rate

      • 18.3.2 Latvia Cell Therapy Market Volume and Growth Rate

      • 18.3.3 Lithuania Cell Therapy Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Astellas Pharma

      • 19.1.1 Astellas Pharma Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Avita Medical

      • 19.2.1 Avita Medical Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Capricor Therapeutics

      • 19.3.1 Capricor Therapeutics Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 BioTissue Technologies

      • 19.4.1 BioTissue Technologies Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Cell Medica

      • 19.5.1 Cell Medica Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 BIOTIME

      • 19.6.1 BIOTIME Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 CellBioMed

      • 19.7.1 CellBioMed Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Caladrius

      • 19.8.1 Caladrius Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Vericel

      • 19.9.1 Vericel Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Biogen Idec

      • 19.10.1 Biogen Idec Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Athersys

      • 19.11.1 Athersys Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Bluebird Bio

      • 19.12.1 Bluebird Bio Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Antibe Therapeutics

      • 19.13.1 Antibe Therapeutics Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Celgene

      • 19.14.1 Celgene Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Dendreon

      • 19.15.1 Dendreon Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Amorcyte

      • 19.16.1 Amorcyte Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 BIOCELLULAR THERAPIES

      • 19.17.1 BIOCELLULAR THERAPIES Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Mesoblast

      • 19.18.1 Mesoblast Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Bellicum Pharmaceuticals

      • 19.19.1 Bellicum Pharmaceuticals Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 AlloCure

      • 19.20.1 AlloCure Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 AxoGen

      • 19.21.1 AxoGen Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Bone Therapeutics

      • 19.22.1 Bone Therapeutics Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 BrainStorm Cell Therapeutics

      • 19.23.1 BrainStorm Cell Therapeutics Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Anterogen

      • 19.24.1 Anterogen Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    • 19.25 BioCardia

      • 19.25.1 BioCardia Company Profile and Development Status

      • 19.25.2 Market Performance

      • 19.25.3 Product and Service Introduction

    • 19.26 Bio-Tissue

      • 19.26.1 Bio-Tissue Company Profile and Development Status

      • 19.26.2 Market Performance

      • 19.26.3 Product and Service Introduction

    The List of Tables and Figures (Totals 116 Figures and 159 Tables)

    • Figure Product Picture

    • Figure Cell Therapy Market Size and Growth Rate of Nanotechnology Market, 2015 - 2026 (USD Million)

    • Figure Cell Therapy Market Size and Growth Rate of Natural Substances Market, 2015 - 2026 (USD Million)

    • Figure Cell Therapy Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • Figure Cell Therapy Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure UK Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure France Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Cell Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Cell Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Cell Therapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cell Therapy by Different Types from 2014 to 2026

    • Table Consumption Share of Cell Therapy by Different Types from 2014 to 2026

    • Figure Cell Therapy Market Size and Growth Rate of Nanotechnology Market, 2015 - 2026 (USD Million)

    • Figure Cell Therapy Market Size and Growth Rate of Natural Substances Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Cell Therapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of Cell Therapy by Different End-Users from 2014 to 2026

    • Figure Cell Therapy Market Size and Growth Rate of Scientific Research from 2014 to 2026

    • Figure Cell Therapy Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Cell Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Cell Therapy Production by Major Regions

    • Table Europe Cell Therapy Production Share by Major Regions

    • Figure Europe Cell Therapy Production Share by Major Countries and Regions in 2014

    • Table Europe Cell Therapy Consumption by Major Regions

    • Table Europe Cell Therapy Consumption Share by Major Regions

    • Table Germany Cell Therapy Production, Import, Consumption and Export Analysis

    • Table UK Cell Therapy Production, Import, Consumption and Export Analysis

    • Table France Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Italy Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Spain Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Poland Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Russia Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Switzerland Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Turkey Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Cell Therapy Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Cell Therapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Cell Therapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Cell Therapy Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Cell Therapy Consumption by Types from 2014 to 2026

    • Table Germany Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Germany Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Germany Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table UK Cell Therapy Consumption by Types from 2014 to 2026

    • Table UK Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table UK Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table UK Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table France Cell Therapy Consumption by Types from 2014 to 2026

    • Table France Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table France Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table France Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Italy Cell Therapy Consumption by Types from 2014 to 2026

    • Table Italy Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Italy Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Italy Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Spain Cell Therapy Consumption by Types from 2014 to 2026

    • Table Spain Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Spain Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Spain Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Poland Cell Therapy Consumption by Types from 2014 to 2026

    • Table Poland Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Poland Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Poland Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Russia Cell Therapy Consumption by Types from 2014 to 2026

    • Table Russia Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Russia Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Russia Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Cell Therapy Consumption by Types from 2014 to 2026

    • Table Switzerland Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Switzerland Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Switzerland Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Cell Therapy Consumption by Types from 2014 to 2026

    • Table Turkey Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Turkey Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Turkey Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cell Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Cell Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Astellas Pharma Profiles

    • Table Astellas Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Astellas Pharma Product benchmarking

    • Table Astellas Pharma Strategic initiatives

    • Table Astellas Pharma SWOT analysis

    • Table Avita Medical Profiles

    • Table Avita Medical Production, Value, Price, Gross Margin 2014-2019

    • Table Avita Medical Product benchmarking

    • Table Avita Medical Strategic initiatives

    • Table Avita Medical SWOT analysis

    • Table Capricor Therapeutics Profiles

    • Table Capricor Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Capricor Therapeutics Product benchmarking

    • Table Capricor Therapeutics Strategic initiatives

    • Table Capricor Therapeutics SWOT analysis

    • Table BioTissue Technologies Profiles

    • Table BioTissue Technologies Production, Value, Price, Gross Margin 2014-2019

    • Table BioTissue Technologies Product benchmarking

    • Table BioTissue Technologies Strategic initiatives

    • Table BioTissue Technologies SWOT analysis

    • Table Cell Medica Profiles

    • Table Cell Medica Production, Value, Price, Gross Margin 2014-2019

    • Table Cell Medica Product benchmarking

    • Table Cell Medica Strategic initiatives

    • Table Cell Medica SWOT analysis

    • Table BIOTIME Profiles

    • Table BIOTIME Production, Value, Price, Gross Margin 2014-2019

    • Table BIOTIME Product benchmarking

    • Table BIOTIME Strategic initiatives

    • Table BIOTIME SWOT analysis

    • Table CellBioMed Profiles

    • Table CellBioMed Production, Value, Price, Gross Margin 2014-2019

    • Table CellBioMed Product benchmarking

    • Table CellBioMed Strategic initiatives

    • Table CellBioMed SWOT analysis

    • Table Caladrius Profiles

    • Table Caladrius Production, Value, Price, Gross Margin 2014-2019

    • Table Caladrius Product benchmarking

    • Table Caladrius Strategic initiatives

    • Table Caladrius SWOT analysis

    • Table Vericel Profiles

    • Table Vericel Production, Value, Price, Gross Margin 2014-2019

    • Table Vericel Product benchmarking

    • Table Vericel Strategic initiatives

    • Table Vericel SWOT analysis

    • Table Biogen Idec Profiles

    • Table Biogen Idec Production, Value, Price, Gross Margin 2014-2019

    • Table Biogen Idec Product benchmarking

    • Table Biogen Idec Strategic initiatives

    • Table Biogen Idec SWOT analysis

    • Table Athersys Profiles

    • Table Athersys Production, Value, Price, Gross Margin 2014-2019

    • Table Athersys Product benchmarking

    • Table Athersys Strategic initiatives

    • Table Athersys SWOT analysis

    • Table Bluebird Bio Profiles

    • Table Bluebird Bio Production, Value, Price, Gross Margin 2014-2019

    • Table Bluebird Bio Product benchmarking

    • Table Bluebird Bio Strategic initiatives

    • Table Bluebird Bio SWOT analysis

    • Table Antibe Therapeutics Profiles

    • Table Antibe Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Antibe Therapeutics Product benchmarking

    • Table Antibe Therapeutics Strategic initiatives

    • Table Antibe Therapeutics SWOT analysis

    • Table Celgene Profiles

    • Table Celgene Production, Value, Price, Gross Margin 2014-2019

    • Table Celgene Product benchmarking

    • Table Celgene Strategic initiatives

    • Table Celgene SWOT analysis

    • Table Dendreon Profiles

    • Table Dendreon Production, Value, Price, Gross Margin 2014-2019

    • Table Dendreon Product benchmarking

    • Table Dendreon Strategic initiatives

    • Table Dendreon SWOT analysis

    • Table Amorcyte Profiles

    • Table Amorcyte Production, Value, Price, Gross Margin 2014-2019

    • Table Amorcyte Product benchmarking

    • Table Amorcyte Strategic initiatives

    • Table Amorcyte SWOT analysis

    • Table BIOCELLULAR THERAPIES Profiles

    • Table BIOCELLULAR THERAPIES Production, Value, Price, Gross Margin 2014-2019

    • Table BIOCELLULAR THERAPIES Product benchmarking

    • Table BIOCELLULAR THERAPIES Strategic initiatives

    • Table BIOCELLULAR THERAPIES SWOT analysis

    • Table Mesoblast Profiles

    • Table Mesoblast Production, Value, Price, Gross Margin 2014-2019

    • Table Mesoblast Product benchmarking

    • Table Mesoblast Strategic initiatives

    • Table Mesoblast SWOT analysis

    • Table Bellicum Pharmaceuticals Profiles

    • Table Bellicum Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Bellicum Pharmaceuticals Product benchmarking

    • Table Bellicum Pharmaceuticals Strategic initiatives

    • Table Bellicum Pharmaceuticals SWOT analysis

    • Table AlloCure Profiles

    • Table AlloCure Production, Value, Price, Gross Margin 2014-2019

    • Table AlloCure Product benchmarking

    • Table AlloCure Strategic initiatives

    • Table AlloCure SWOT analysis

    • Table AxoGen Profiles

    • Table AxoGen Production, Value, Price, Gross Margin 2014-2019

    • Table AxoGen Product benchmarking

    • Table AxoGen Strategic initiatives

    • Table AxoGen SWOT analysis

    • Table Bone Therapeutics Profiles

    • Table Bone Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Bone Therapeutics Product benchmarking

    • Table Bone Therapeutics Strategic initiatives

    • Table Bone Therapeutics SWOT analysis

    • Table BrainStorm Cell Therapeutics Profiles

    • Table BrainStorm Cell Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table BrainStorm Cell Therapeutics Product benchmarking

    • Table BrainStorm Cell Therapeutics Strategic initiatives

    • Table BrainStorm Cell Therapeutics SWOT analysis

    • Table Anterogen Profiles

    • Table Anterogen Production, Value, Price, Gross Margin 2014-2019

    • Table Anterogen Product benchmarking

    • Table Anterogen Strategic initiatives

    • Table Anterogen SWOT analysis

    • Table BioCardia Profiles

    • Table BioCardia Production, Value, Price, Gross Margin 2014-2019

    • Table BioCardia Product benchmarking

    • Table BioCardia Strategic initiatives

    • Table BioCardia SWOT analysis

    • Table Bio-Tissue Profiles

    • Table Bio-Tissue Production, Value, Price, Gross Margin 2014-2019

    • Table Bio-Tissue Product benchmarking

    • Table Bio-Tissue Strategic initiatives

    • Table Bio-Tissue SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US